PIGMENT study: Pathogenic cells and mediators in pigment cell disorders of the ski
- Conditions
- Pigment cell disorders10035023
- Registration Number
- NL-OMON56194
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 2500
Patients:
• Patients with pigment cell disorders: vitiligo, genetic pigment cell
disorders (e.g. piebaldism, nevus depigmentosis, segmental hypomelanosis) or
pityriasis
• Age >=18
• Patient is willing and able to give written informed consent
Healthy Donors:
• Age >=18
• Patient is willing and able to give written informed consent
Patients:
• Hypertrophic scars.
• Keloid.
• Patients with a history of hypersensitivity or allergy to local anaesthesia.
• Patients with haemophilia or other clotting disorders.
• Patients not competent to understand what the procedures involves.
Healthy Donors:
•• People with pigment cell disorders: vitiligo, genetic pigment cell
disorders (e.g. piebaldism, nevus depigmentosis, segmental hypomelanosis) or
pityriasis
• Hypertrophic scars
• Keloid
• People with a history of hypersensitivity or allergy to local anaesthesia
• People with haemophilia or other clotting disorders
• People who are competent to understand what the procedures involve
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method